2021
DOI: 10.1016/j.yrtph.2021.105016
|View full text |Cite
|
Sign up to set email alerts
|

Application of the 3Rs principles in the development of pharmaceutical generics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…Fungal diseases are associated with high mortality rates, and instances of resistant strains are on the rise [ 7 ]. Furthermore, research focusing on the pathophysiology of fungal infections needs further exploration to identify new therapeutic targets and develop novel classes of antifungal drugs [ 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Fungal diseases are associated with high mortality rates, and instances of resistant strains are on the rise [ 7 ]. Furthermore, research focusing on the pathophysiology of fungal infections needs further exploration to identify new therapeutic targets and develop novel classes of antifungal drugs [ 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, many countries have enacted legislation to curtail mammalian usage in specific sectors, including animal experimentation, thereby intensifying the scrutiny of these methodologies. The 3 Rs principle (replacement, reduction, and refinement) has been incorporated into legislation and animal experimentation guidelines across numerous countries [ 8 , 11 ]. These principles advocate replacing research animals with systems and strategies that yield more robust and dependable data [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation